Cooper Looks to Finish Fiscal 2026 on Weak Note From US Channel Destocking and APAC Challenges
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical.
The Cooper Companies Inc COO
Bulls Say, Bears Say
Bulls
Cooper is one of the leading visioncare companies in the world with a proven record of successful product development. Recent innovations like MiSight widen Cooper's end market and fuel the firm's future growth trajectory.
Bears
While the contact lens market share has been stable, lagging research and innovation could start to chip away at Cooper's presence in the space.
News
-
Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Cooper Companies, Inc. - COO
-
Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Cooper Companies, Inc. - COO
-
Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Cooper Companies, Inc. - COO
-
Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COO
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Cooper Companies, Inc. - COO
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 190.16M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 12.80
- Price/Sales
- 2.73
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 5.74%
Company Profile
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 15,000
- Website
- https://www.coopercos.com
Competitors
Valuation
|
Metric
|
COO
|
ALC
|
JNJ
|
|---|---|---|---|
Price/Earnings (Normalized) | 12.80 | 31.84 | 27.25 |
Price/Book Value | 1.35 | 1.51 | 7.62 |
Price/Sales | 2.73 | 3.05 | 6.35 |
Price/Cash Flow | 12.20 | 12.84 | 29.29 |
Price/Earnings
COO
ALC
JNJ
Financial Strength
|
Metric
|
COO
|
ALC
|
JNJ
|
|---|---|---|---|
Quick Ratio | 0.51 | 1.12 | 0.65 |
Current Ratio | 1.22 | 2.09 | 1.02 |
Interest Coverage | 6.18 | 4.19 | 18.14 |
Quick Ratio
COO
ALC
JNJ
Profitability
|
Metric
|
COO
|
ALC
|
JNJ
|
|---|---|---|---|
Return on Assets (Normalized) | 7.25% | 5.09% | 13.13% |
Return on Equity (Normalized) | 10.89% | 7.28% | 31.88% |
Return on Invested Capital (Normalized) | 9.02% | 6.30% | 20.08% |
Return on Assets
COO
ALC
JNJ
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|@<NJlFDL | LOCK|LQ | $151B | |||
| Becton Dickinson & Co
BDX
| LOCK|%?r | LOCK|^<kF? | $53B | |||
| ResMed Inc
RMD
| LOCK|&z$!g#?n | LOCK|w>&r | $35B | |||
| Alcon Inc
ALC
| LOCK|PVsGB@$ | LOCK|^!w^ | $33B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|@#ZFg^ | LOCK|p@t$ | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|Vy!?@@# | LOCK|#P | $28B | |||
| Solventum Corp
SOLV
| LOCK|r@hXkB | LOCK|x#@ | $15B | |||
| Baxter International Inc
BAX
| LOCK|$$ | LOCK|Clfg | $13B | |||
| Repligen Corp
RGEN
| LOCK|!^!#M#f | LOCK|!TF@ | $11B |
United States